IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID L STOCKMAN

Allopathic & Osteopathic Physicians Dermatology Dermatopathology

NPI
1407086424
CMS profile
744996
Location
SAGINAW, MI

General Payments · PY2018–2024

$23,552.20

  • Reported across 159 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$22,063.56

48 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Dermatopathology MI All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Debt forgiveness $21,456.19 1
Food and Beverage $607.37 47

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Biofrontera Inc. $21,456.19 1
NOVARTIS PHARMACEUTICALS CORPORATION $217.74 29
Regeneron Healthcare Solutions, Inc. $70.22 3
Amgen Inc. $59.92 2
GENZYME CORPORATION $51.43 2
PFIZER INC. $43.24 3
Boehringer Ingelheim Pharmaceuticals, Inc. $30.38 1
UCB, Inc. $26.47 1
Xeris Pharmaceuticals, Inc. $21.20 1
SOBI, INC $21.18 1
Acerta Pharma LLC $19.70 1
Arcutis Biotherapeutics, Inc. $16.39 1
Verrica Pharmaceuticals Inc. $15.17 1
E.R. Squibb & Sons, L.L.C. $14.33 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $161.07 17
PY2019 $68.47 5
PY2020 $78.44 2
PY2021 $219.83 13
PY2022 $474.77 34
PY2023 $486.06 40
PY2024 $22,063.56 48

Payment records · PY2024 (48)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $28.82 03/12/2024 Food and Beverage Undisputed 01/23/2026 1117392224 CMS
Amgen Inc. $31.10 04/24/2024 Food and Beverage Undisputed 01/23/2026 1117392226 CMS
Arcutis Biotherapeutics, Inc. $16.39 12/02/2024 Food and Beverage Undisputed 01/23/2026 1121043490 CMS
AstraZeneca Pharmaceuticals LP $19.70 01/24/2024 Food and Beverage Undisputed 01/23/2026 1104619550 CMS
Biofrontera Inc. $21,456.19 10/25/2024 Debt forgiveness Undisputed 01/23/2026 1147270930 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $30.38 04/22/2024 Food and Beverage Undisputed 01/23/2026 1117995644 CMS
E.R. Squibb & Sons, L.L.C. $14.33 10/22/2024 Food and Beverage Undisputed 01/23/2026 1101286162 CMS
GENZYME CORPORATION $24.92 01/17/2024 Food and Beverage Undisputed 01/23/2026 1139692456 CMS
GENZYME CORPORATION $26.51 07/15/2024 Food and Beverage Undisputed 01/23/2026 1139692512 CMS
Novartis Pharmaceuticals Corporation $12.89 02/06/2024 Food and Beverage Undisputed 01/23/2026 1087288481 CMS
Novartis Pharmaceuticals Corporation $2.02 02/06/2024 Food and Beverage Undisputed 01/23/2026 1087288483 CMS
Novartis Pharmaceuticals Corporation $2.51 02/27/2024 Food and Beverage Undisputed 01/23/2026 1087288509 CMS
Novartis Pharmaceuticals Corporation $15.20 02/27/2024 Food and Beverage Undisputed 01/23/2026 1087288511 CMS
Novartis Pharmaceuticals Corporation $1.61 03/01/2024 Food and Beverage Undisputed 01/23/2026 1087288505 CMS
Novartis Pharmaceuticals Corporation $32.79 03/04/2024 Food and Beverage Undisputed 01/23/2026 1087288485 CMS
Novartis Pharmaceuticals Corporation $1.22 03/12/2024 Food and Beverage Undisputed 01/23/2026 1087288507 CMS
Novartis Pharmaceuticals Corporation $1.29 04/04/2024 Food and Beverage Undisputed 01/23/2026 1087288495 CMS
Novartis Pharmaceuticals Corporation $15.47 04/18/2024 Food and Beverage Undisputed 01/23/2026 1087288517 CMS
Novartis Pharmaceuticals Corporation $1.26 04/18/2024 Food and Beverage Undisputed 01/23/2026 1087288521 CMS
Novartis Pharmaceuticals Corporation $1.20 05/06/2024 Food and Beverage Undisputed 01/23/2026 1087288519 CMS
Novartis Pharmaceuticals Corporation $15.20 05/06/2024 Food and Beverage Undisputed 01/23/2026 1087288523 CMS
Novartis Pharmaceuticals Corporation $1.17 05/16/2024 Food and Beverage Undisputed 01/23/2026 1087288527 CMS
Novartis Pharmaceuticals Corporation $9.18 05/21/2024 Food and Beverage Undisputed 01/23/2026 1087288529 CMS
Novartis Pharmaceuticals Corporation $2.91 06/11/2024 Food and Beverage Undisputed 01/23/2026 1087288531 CMS
Novartis Pharmaceuticals Corporation $15.60 06/11/2024 Food and Beverage Undisputed 01/23/2026 1087288533 CMS
Novartis Pharmaceuticals Corporation $6.83 07/12/2024 Food and Beverage Undisputed 01/23/2026 1087288543 CMS
Novartis Pharmaceuticals Corporation $1.51 08/07/2024 Food and Beverage Undisputed 01/23/2026 1087288549 CMS
Novartis Pharmaceuticals Corporation $16.46 08/07/2024 Food and Beverage Undisputed 01/23/2026 1087288551 CMS
Novartis Pharmaceuticals Corporation $1.34 08/21/2024 Food and Beverage Undisputed 01/23/2026 1087288557 CMS
Novartis Pharmaceuticals Corporation $2.41 09/03/2024 Food and Beverage Undisputed 01/23/2026 1087288559 CMS
Novartis Pharmaceuticals Corporation $16.93 09/03/2024 Food and Beverage Undisputed 01/23/2026 1087288561 CMS
Novartis Pharmaceuticals Corporation $1.37 09/24/2024 Food and Beverage Undisputed 01/23/2026 1087288569 CMS
Novartis Pharmaceuticals Corporation $1.16 11/01/2024 Food and Beverage Undisputed 01/23/2026 1087288573 CMS
Novartis Pharmaceuticals Corporation $14.28 11/05/2024 Food and Beverage Undisputed 01/23/2026 1087288575 CMS
Novartis Pharmaceuticals Corporation $4.50 11/05/2024 Food and Beverage Undisputed 01/23/2026 1087288577 CMS
Novartis Pharmaceuticals Corporation $1.29 11/20/2024 Food and Beverage Undisputed 01/23/2026 1087288581 CMS
Novartis Pharmaceuticals Corporation $16.83 12/03/2024 Food and Beverage Undisputed 01/23/2026 1087288583 CMS
Novartis Pharmaceuticals Corporation $1.31 12/10/2024 Food and Beverage Undisputed 01/23/2026 1087288591 CMS
PFIZER INC. $14.54 02/06/2024 Food and Beverage Undisputed 01/23/2026 1131718323 CMS
PFIZER INC. $15.22 07/11/2024 Food and Beverage Undisputed 01/23/2026 1131773159 CMS
PFIZER INC. $13.48 10/28/2024 Food and Beverage Undisputed 01/23/2026 1131122501 CMS
Regeneron Healthcare Solutions, Inc. $26.79 06/24/2024 Food and Beverage Undisputed 01/23/2026 1114197060 CMS
Regeneron Healthcare Solutions, Inc. $19.80 08/28/2024 Food and Beverage Undisputed 01/23/2026 1114197066 CMS
Regeneron Healthcare Solutions, Inc. $23.63 11/18/2024 Food and Beverage Undisputed 01/23/2026 1114197072 CMS
SOBI, INC $21.18 07/08/2024 Food and Beverage Undisputed 01/23/2026 1141418720 CMS
UCB, Inc. $26.47 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143044995 CMS
Verrica Pharmaceuticals Inc. $15.17 02/08/2024 Food and Beverage Undisputed 01/23/2026 1118387258 CMS
Xeris Pharmaceuticals, Inc. $21.20 01/09/2024 Food and Beverage Undisputed 01/23/2026 1144592186 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.